초록 ▼

This invention provides a microparticle carrier system comprising of one or more proteins, peptides, nucleic acids, carbohydrates, lipids or other bioactive substances with or without targeting molecules attached. In addition, the invention also provides immune modulatory compositions and methods of

This invention provides a microparticle carrier system comprising of one or more proteins, peptides, nucleic acids, carbohydrates, lipids or other bioactive substances with or without targeting molecules attached. In addition, the invention also provides immune modulatory compositions and methods of eliciting protective immune responses both in uninfected and infected hosts as well as the induction of immune tolerance.

대표청구항 ▼

1. An immunologically active composition to induce protective immunity, the composition comprising: (a) at least one pathogen associated molecular pattern;(b) at least one immune active antigen; and(c) at least one carrier, wherein the carrier comprises agarose microparticles, and wherein the at lea

1. An immunologically active composition to induce protective immunity, the composition comprising: (a) at least one pathogen associated molecular pattern;(b) at least one immune active antigen; and(c) at least one carrier, wherein the carrier comprises agarose microparticles, and wherein the at least one pathogen associated molecular pattern and the at least one immune active antigen are covalently bound to the agarose microparticles. 2. The composition of claim 1 wherein the at least one immune active antigen does not include an escape epitope. 3. The composition of claim 1, wherein the immune active antigen is a peptide, protein, a recombinant peptide, a recombinant protein, lipid, or carbohydrate. 4. The composition of claim 1, wherein the immune active antigen is a peptide or protein and wherein the peptide or protein possesses immunomodulatory motifs. 5. The composition of claim 1, wherein the immune active antigen is a peptide or protein and wherein the peptide or protein possesses at least one modification involving a carbohydrate moiety, a lipid moiety, or both a carbohydrate and a lipid moiety. 6. The composition of claim 5, wherein the modification contains terminal mannosylation. 7. The composition of claim 5, wherein the modification involves lipid moieties. 8. The composition of claim 1, wherein the immune active antigen is a peptide or protein and wherein the immune active peptide or protein has no modifications involving a carbohydrate moiety, a lipid moiety, or both a carbohydrate and a lipid moiety. 9. The composition of claim 1, wherein the immune active antigen is a peptide or protein and wherein the immune active peptide or protein does not possess amino acid sequences capable of N-glycosylation and/or lipoylation. 10. The composition of claim 1, wherein the immune active antigen is a peptide or protein and wherein the immune active protein or peptide possesses amino acid sequences capable of binding cell surface entry receptors. 11. An immunologically active composition to induce protective immunity, the composition comprising: (a) at least one pathogen associated molecular pattern;(b) at least one immune active antigen; and(c) at least one carrier, wherein the carrier comprises agarose microparticles,wherein the at least one pathogen associated molecular pattern and the at least one immune active antigen are covalently bound to the agarose microparticles; andwherein the immune active antigen is a peptide or protein and wherein the immune active protein or peptide possesses amino acid sequences capable of binding cell surface glycosaminoglycans (GAGs). 12. An immunologically active composition to induce protective immunity, the composition comprising: (a) at least one pathogen associated molecular pattern;(b) at least one immune active antigen; and(c) at least one carrier, wherein the carrier comprises agarose microparticles,wherein the at least one pathogen associated molecular pattern and the at least one immune active antigen are covalently bound to the agarose microparticles; andwherein the immune active antigen is a peptide or protein and wherein the immune active protein or peptide possesses amino acid sequences capable of binding cell surface entry receptors; andwherein the amino acid sequences are polybasic in nature. 13. The composition of claim 12, wherein the amino acid sequences have the general formula of XBBXBX, XBBBXXBX, BBXXBBBXXBB, BBBXXB, BXBXB, BBB, BXBXXXBXB, or BXBXXXXXBXB wherein B is a basic amino acid and X is any other amino acid. 14. The composition of claim 11, wherein the GAG binding amino acid sequences are capable of generating antibodies to the peptide or protein that are capable of interfering with pathogen binding to cell surfaces. 15. The composition of claim 1, wherein the immune active antigen is capable of generating antibodies to the antigen capable of interfering with pathogen binding to cell entry receptors. 16. The composition of claim 1, wherein the immune active antigen is capable of inducing antibodies capable of interfering with entry into the cell. 17. The composition of claim 1, wherein the immune active antigen is capable of inducing antibodies capable of binding and activating complement. 18. The composition of claim 1, wherein the immune active antigen includes either or both T-cell epitopes and B-cell epitopes. 19. An immunologically active composition to induce protective immunity, the composition comprising: (a) at least one pathogen associated molecular pattern;(b) at least one immune active antigen; and(c) at least one carrier, wherein the carrier comprises agarose microparticles,wherein the at least one pathogen associated molecular pattern and the at least one immune active antigen are covalently bound to the agarose microparticles; andwherein the immune active antigen is a peptide or protein and is able to elicit antibodies that can interfere with the binding of N-glycosylation and/or lipoylation sequences to their receptors in the host. 20. An immunologically active composition to induce protective immunity, the composition comprising: (a) at least one pathogen associated molecular pattern;(b) at least one immune active antigen; and(c) at least one carrier, wherein the carrier comprises agarose microparticles,wherein the at least one pathogen associated molecular pattern and the at least one immune active antigen are covalently bound to the agarose microparticles; andwherein the immune active antigen is a peptide or protein and is able to elicit antibodies that can interfere with the binding of N-glycosylation and/or lipoylation sequences to the DC-SIGN, L-SIGN or similar receptors in the host. 21. An immunologically active composition to induce protective immunity, the composition comprising: (a) at least one pathogen associated molecular pattern;(b) at least one immune active antigen; and(c) at least one carrier, wherein the carrier comprises agarose microparticles,wherein the at least one pathogen associated molecular pattern and the at least one immune active antigen are covalently bound to the agarose microparticles; andwherein the immune active antigen is a peptide or protein and is able to elicit antibodies that can interfere with the binding of N-glycosylation and/or lipoylation sequences to their receptors in the host and prevent or reduce IL-10 production. 22. The composition of claim 1, wherein the pathogen associated molecular pattern is selected from the group consisting of: (a) a TLR 1 receptor agonist;(b) a TLR 2 receptor agonist;(c) a TLR 3 receptor agonist;(d) a TLR 4 receptor agonist;(e) a TLR 5 receptor agonist;(f) a TLR 6 receptor agonist;(g) a TLR 7 receptor agonist;(h) a TLR 8 receptor agonist;(i) a TLR 9 receptor agonist;(j) a NOD-1 agonist;(k) a NOD-2 agonist;(l) an agonist for DC-SIGN;(m) an agonist for L-SIGN; and(n) an agonist for a mannose receptor. 23. An immunologically active composition to induce protective immunity, the composition comprising: (a) at least one pathogen associated molecular pattern;(b) at least one immune active antigen; and(c) at least one carrier, wherein the carrier comprises agarose microparticles,wherein the at least one pathogen associated molecular pattern and the at least one immune active antigen are covalently bound to the agarose microparticles; andwherein the pathogen associated molecular pattern is a NOD-1 agonist or a NOD-2 agonist and the NOD-1 agonist or NOD-2 agonist is selected from the group consisting of bacterial peptidoglycan and a derivative of bacterial peptidoglycan. 24. The composition of claim 1, wherein the agarose microparticles are porous. 25. The composition of claim 1 comprising more than one immune active antigen covalently attached to the agarose microparticles. 26. The composition of claim 1, wherein more than one immune active antigen and more than one pattern recognition receptor agonist are covalently bound to the agarose microparticles. 27. An immunologically active composition to induce protective immunity, the composition comprising: (a) at least one pathogen associated molecular pattern;(b) at least one immune active antigen; and(c) at least one carrier, wherein the carrier comprises agarose microparticles,wherein the at least one pathogen associated molecular pattern and the at least one immune active antigen are covalently bound to the agarose microparticles; andwherein the immune active antigen is a peptide or protein and wherein the peptide or protein possesses immunomodulatory motifs that are hydrophobic in nature and have additional molecules attached to them. 28. The composition of claim 5, wherein the peptide or protein possesses at least one modification involving a carbohydrate moiety, wherein any immunomodulatory terminally mannosylated substances are depleted from the composition by a step selected from the group consisting of an oxidative step, enzymatic treatment, and sugar-specific affinity binding.